Tanke Biosciences Corporation (TNBI)

Tanke Biosciences Corporation (TNBI) Financial Services Profile

Tanke Biosciences Corporation, established in 1989, operates in the animal nutrition and feed additive market, offering a diverse portfolio of organic trace minerals, functional additives, and herbal medicinal products under brands like Qili and Tankeball. The company serves feed producers and farmers across China, Southeast Asia, and Latin America, positioning itself within a specialized segment of the agricultural supply chain.

What Is the Investment Thesis for TNBI?

Tanke Biosciences Corporation presents an investment profile centered on its established presence within the animal nutrition and feed additive market, particularly across the People's Republic of China, Southeast Asia, and Latin America. The company's diversified product portfolio, encompassing organic trace minerals, functional additives, and herbal medicinal solutions under recognized brands like Qili and Tankeball, addresses critical needs in animal health and feed efficiency. A notable financial characteristic is its robust gross margin of 88.4%, indicating strong pricing power or efficient production costs for its specialized products. However, this is juxtaposed with a significant negative profit margin of -2536.4%, suggesting substantial operational expenses or other financial challenges impacting overall profitability. Growth catalysts could emerge from expanding its market share in existing geographies, introducing new specialized additives to meet evolving animal husbandry demands, or capitalizing on increasing global demand for sustainable and efficient animal protein production. The company's direct engagement with mid-to-large feed factories and farmers provides a stable customer base. Key risks include the current unprofitability, competitive pressures in the feed additive market, and potential regulatory changes in its primary operating regions. The company's classification as a 'Shell Company' within the 'Financial Services' sector, despite its operational focus on animal nutrition, also warrants careful consideration for investors.

Based on FMP financials and quantitative analysis

TNBI Key Highlights

• Gross Margin of 88.4% indicates strong product profitability at the cost of goods sold level, significantly above many industry averages.
• Profit Margin of -2536.4% highlights substantial operational or non-operating expenses leading to significant net losses.
• Beta of -1.14 suggests an inverse relationship with the broader market, indicating potential for counter-cyclical movements, though this can also imply higher volatility or specific market dynamics.
• The company operates across four distinct segments: Organic Trace Mineral Additives, Functional Regulation Additives, Herbal Medicinal Additives, and Other, showcasing a diversified product strategy.
• Geographic reach spans the People's Republic of China, Southeast Asia, and Latin America, providing exposure to diverse and growing agricultural markets.

Who Are TNBI's Competitors?

TNBI is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are TNBI's Key Strengths?

• Diverse product portfolio addressing multiple animal nutrition needs, including organic trace minerals, functional additives, and herbal solutions.
• Strong gross margin of 88.4% indicates efficient production or premium pricing for its specialized products.
• Established presence and sales network across key agricultural markets in China, Southeast Asia, and Latin America.
• Proprietary brands like Qili, Qilicid, and Tankeball are recognized within specific product categories.
• Focus on specialized and natural feed additives aligns with evolving industry trends towards sustainable animal husbandry.

What Are TNBI's Weaknesses?

• Significant negative profit margin of -2536.4% indicates substantial unprofitability at the net income level.
• Limited public disclosure status as 'Unknown' on the OTC market, potentially hindering investor confidence and transparency.
• The official classification as a 'Shell Company' within 'Financial Services' despite an active animal nutrition business creates ambiguity.
• Small market capitalization of 319K suggests very limited or no public trading activity and liquidity challenges.
• Reliance on a relatively small employee base (130 employees) for a company with international reach and diverse product lines.

What Could Drive TNBI Stock Higher?

• Improved financial reporting and disclosure status on the OTC market could enhance investor confidence and transparency.
• Successful introduction of new, innovative animal nutrition products that gain significant market traction in key regions.
• Strategic partnerships or distribution agreements that expand the company's reach into new agricultural markets or customer segments.
• A return to profitability, indicated by a positive shift from the current negative profit margin, signaling operational efficiency improvements.
• Increased demand for specialized organic or herbal feed additives, aligning with the company's product portfolio, driven by global market trends.

What Are the Key Risks for TNBI?

• Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
• The significant negative profit margin of -2536.4% indicates severe unprofitability, posing a substantial risk to long-term viability.
• The 'Unknown' disclosure status on the OTC market creates a high level of information asymmetry and uncertainty for investors.
• Extremely low market capitalization and potential illiquidity make it difficult for investors to trade shares effectively.
• Intense competition within the animal nutrition and feed additive industry from larger, better-capitalized players.
• Regulatory changes or trade barriers in the People's Republic of China, Southeast Asia, or Latin America could negatively impact sales and operations.

What Are the Growth Opportunities for TNBI?

• Growth opportunity 1: Expansion of specialized organic trace mineral additives. The global market for organic trace minerals in animal feed is projected to grow due to increasing awareness of their bioavailability and environmental benefits compared to inorganic alternatives. Tanke Biosciences' Qili brand is well-positioned to capitalize on this trend, particularly in its established markets of China and Southeast Asia, where intensive animal farming practices are prevalent. By enhancing research and development into novel organic chelates and expanding production capacity, the company could capture a larger share of this market, which is expected to see sustained growth over the next 5-7 years as producers seek to optimize animal health and reduce environmental impact.
• Growth opportunity 2: Increased adoption of functional regulation additives. The demand for feed acidifiers and other functional additives, such as those under the Qilicid name, is rising as livestock producers aim to improve gut health, reduce antibiotic use, and enhance nutrient absorption in animals. This segment is driven by consumer preferences for healthier meat products and regulatory pressures to minimize antimicrobial resistance. Tanke Biosciences can expand its market penetration by demonstrating the efficacy of its functional additives in improving feed conversion ratios and animal immunity, particularly in regions like Latin America where livestock production is a significant economic activity. This opportunity is ongoing and expected to intensify over the next decade.
• Growth opportunity 3: Leveraging herbal medicinal additives for animal health. The market for natural and herbal solutions in animal feed is experiencing significant growth as an alternative to synthetic medications, driven by a global shift towards sustainable and 'clean label' animal products. Tanke Biosciences' Extra-Health, Qilimix, and Recoccider brands offer a portfolio of herbal medicinal additives that can address various animal health challenges. By investing in clinical trials and demonstrating the scientific basis for these products, the company can enhance their credibility and market acceptance among farmers and feed producers seeking natural ways to boost animal immunity and performance. This represents a long-term growth opportunity over the next 10-15 years.
• Growth opportunity 4: Diversification and innovation in flavor enhancers and attractants. The use of flavor enhancers and attractants, such as those under the Tankeball name, is crucial for improving feed intake and palatability, especially for young animals or during periods of stress. As animal nutrition science advances, there is a continuous need for more effective and species-specific attractants. Tanke Biosciences can capitalize on this by developing new formulations tailored for different animal species (e.g., specific fish species, poultry breeds) and life stages, potentially expanding its market within the aquaculture and swine industries. This ongoing opportunity allows for continuous product innovation and market differentiation.
• Growth opportunity 5: Expanding market reach for multi-vitamin electrolyte products. The water-soluble organic multi-vitamin electrolyte product offered by Tanke Biosciences addresses a fundamental need for animal hydration and nutrient supplementation, particularly in high-stress environments or during disease recovery. With increasing intensification of animal farming globally, the demand for such supportive nutritional products is consistently high. The company can pursue growth by strengthening its distribution networks in existing markets and exploring new emerging markets with significant livestock populations. Emphasizing the ease of administration and comprehensive nutritional benefits can drive adoption among farmers seeking practical solutions for animal welfare and productivity, representing an ongoing opportunity for market expansion.

What Opportunities Does TNBI Have?

• Expanding global demand for high-quality animal protein and sustainable animal feed additives, particularly in emerging markets.
• Growing consumer and regulatory preference for natural, organic, and antibiotic-free animal products, aligning with Tanke's herbal and organic offerings.
• Potential for strategic partnerships or acquisitions to expand product lines, market reach, or technological capabilities.
• Innovation in feed additive formulations to address new animal health challenges or improve feed conversion efficiency.
• Capitalizing on increased awareness among farmers regarding the economic benefits of advanced nutrition for livestock and aquaculture.

What Threats Does TNBI Face?

• Intense competition from larger, more established global animal nutrition companies with greater R&D and marketing resources.
• Fluctuations in raw material costs, which could impact the high gross margin if not managed effectively.
• Regulatory changes in key operating regions regarding feed additive approvals, usage, or environmental standards.
• Outbreaks of animal diseases, which could reduce demand for feed additives or disrupt supply chains.
• Economic downturns or trade disputes in China, Southeast Asia, or Latin America impacting agricultural spending and demand for products.

What Are TNBI's Competitive Advantages?

• Diversified product portfolio covering multiple critical aspects of animal nutrition and health, reducing reliance on a single product line.
• Established brand names such as Qili, Qilicid, and Tankeball, which may foster customer loyalty and recognition in target markets.
• Geographic presence in key agricultural regions like China, Southeast Asia, and Latin America, providing access to large and growing markets.
• Specialization in organic trace minerals and herbal medicinal additives, catering to an increasingly health-conscious and natural-product-oriented market segment.
• Proprietary formulations and manufacturing processes for specialized feed additives, potentially offering a competitive edge in product efficacy.

What Does TNBI Do?

Tanke Biosciences Corporation, founded in 1989 and headquartered in Guangzhou, People's Republic of China, has evolved into a developer, producer, marketer, and seller of animal nutrition and feed additive products through its various subsidiaries. The company's operational framework is segmented into four primary areas: Organic Trace Mineral Additives, Functional Regulation Additives, Herbal Medicinal Additives, and Other, reflecting a comprehensive approach to animal health and feed enhancement. Under the Qili brand name, Tanke Biosciences offers organic trace mineral additives crucial for animal development. Its product line also includes Qilicid, a range of feed acidifiers designed to prevent microbial degradation in raw materials and finished feeds, thereby extending shelf life and ensuring feed quality. The company further provides seasonings and flavor enhancers, marketed under the Tankeball name, which are utilized as agents in the production of blended feeds to improve palatability and consumption rates for livestock and poultry. Herbal medicinal additives, blended directly with feed products, are offered under brands such as Extra-Health, Qilimix, and Recoccider, aiming to support animal well-being through natural compounds. Additionally, Tanke Biosciences produces and markets multiple trace mineral premix products specifically formulated for livestock and poultry, also under the Qilimix brand. The Tankeball brand extends to natural sweeteners and attractants, tailored for use with feed for pigs, piglets, fish, and other aquatic animals, enhancing feed intake. A water-soluble organic multi-vitamin electrolyte product is also part of its portfolio, administered to animals through drinking water to provide essential nutrients. Tanke Biosciences Corporation primarily serves a broad customer base that includes mid-to-large sized feed product factories, large-scale feed producers, and individual farmers. Its market reach extends significantly across the People's Republic of China, with additional sales operations in Southeast Asia and Latin America, indicating a strategic focus on key agricultural regions.

What Products and Services Does TNBI Offer?

• Develops and produces animal nutrition and feed additive products.
• Markets and sells organic trace mineral additives under the Qili brand.
• Offers feed acidifiers, such as Qilicid, to prevent microbial degradation of feed materials.
• Provides seasonings and flavor enhancers, including the Tankeball brand, for blended feeds.
• Manufactures herbal medicinal additives like Extra-Health, Qilimix, and Recoccider for animal health.
• Produces multiple trace mineral premix products for livestock and poultry under the Qilimix name.
• Supplies natural sweeteners and attractants for pigs, piglets, fish, and other aquatic animals (Tankeball brand).
• Distributes water-soluble organic multi-vitamin electrolytes for animal consumption via drinking water.

How Does TNBI Make Money?

• Research, development, and manufacturing of a diversified portfolio of animal nutrition and feed additive products.
• Sales of proprietary branded products (e.g., Qili, Qilicid, Tankeball, Qilimix) directly to mid-to-large sized feed product factories and large-scale feed producers.
• Direct sales to individual farmers, particularly for specialized additives and supplements.
• Revenue generation through the sale of products across four segments: Organic Trace Mineral Additives, Functional Regulation Additives, Herbal Medicinal Additives, and Other.
• Geographic market penetration focused on the People's Republic of China, Southeast Asia, and Latin America.

What Industry Does TNBI Operate In?

Tanke Biosciences Corporation operates within the specialized segment of animal nutrition and feed additives, a critical component of the broader agricultural industry. This market is driven by global demand for efficient and healthy animal protein production, necessitating advanced feed solutions. Key trends include a growing emphasis on natural and organic additives, disease prevention through nutrition, and sustainable farming practices. The competitive landscape for animal feed additives is fragmented, featuring both large multinational corporations and specialized regional players. Tanke Biosciences, with its focus on organic trace minerals, functional regulation additives, and herbal medicinal products, positions itself by offering specialized solutions that cater to specific animal health and growth requirements. Its primary markets in China, Southeast Asia, and Latin America represent regions with significant livestock and aquaculture industries, where demand for improved feed efficiency and animal welfare products is consistently expanding. The company's ability to innovate and differentiate its product offerings will be crucial for navigating this dynamic market.

Who Are TNBI's Key Customers?

• Mid-to-large sized feed product factories that incorporate Tanke's additives into their blended feed formulations.
• Large-scale feed producers requiring specialized ingredients for livestock and poultry nutrition.
• Individual farmers seeking to enhance the health, growth, and productivity of their animals through direct supplementation.
• Aquaculture operations utilizing specific attractants and nutrients for fish and other aquatic animals.
• Livestock operations, including swine and poultry farms, that benefit from trace minerals, acidifiers, and herbal remedies.

ROE 58%Key Financial Metrics

Return on equity for Tanke Biosciences Corporation stands at 58.0%, a gauge of how efficiently it converts shareholder capital into profit. Its free cash flow yield is -1.3%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.03 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -42.0%, the inverse of the P/E and a quick read on earnings relative to price.

Tanke Biosciences Corporation (TNBI) Valuation Context

Valued at 319K, TNBI is classified as a micro-cap stock. Relative to its peer group, TNBI's quantitative score of 58/100 is roughly in line with the peer average of 66/100.

Company Profile

Tanke Biosciences Corporation operates in the Shell Companies industry within the Financial Services sector. It is headquartered in Las Vegas, CN. The company is led by CEO Vincent W. Renz Jr.. TNBI has traded publicly since 2012.

F-Score 2/9Financial Health

Tanke Biosciences Corporation's Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.

TNBI Financials

TNBI Latest News

No recent news available for TNBI.

TNBI Analyst Consensus

TNBI MoonshotScore

Tanke Biosciences Corporation Financial Services Stock: Key Questions Answered

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources